Other Financial Data (Tables)

12 Months Ended

Sep. 30, 2021

Disclosure Text Block [Abstract]

Other Items Reported In Earnings

Items reported in earnings during the years ended September 30 included the following:

	2019		2020	2021
Research and development expense	$	454	439	485
Rent expense	$	285	239	228

Depreciation and Amortization Expense Components

The components of depreciation and amortization expense reported for the years ended September 30 included the following:

	2019		2020	2021
Depreciation expense	$	463	485	499
Amortization of intangibles (includes $15, $17 and $57 reported in Cost of Sales in    2019, 2020 and 2021, respectively) (a)	253		256	357
Amortization of capitalized software	106		113	113
Total	$	822	854	969

Other Assets

Items reported in other noncurrent assets included the following:

	2020		2021
Pension assets	$	265	1,015
Operating lease right-of-use assets	$	508	558
Deferred income taxes	$	99	115
Asbestos-related insurance receivables	$	100	95

Accrued Expenses

Items reported in accrued expenses included the following:

	2020		2021
Customer advances (contract liabilities)	$	583	730
Employee compensation	$	577	690
Operating lease liabilities (current)	$	148	155
Product warranty	$	148	146

Other Liabilities

Other liabilities are summarized as follows:

	2020		2021
Deferred income taxes	$	261	711
Pension and postretirement liabilities	769		676
Operating lease liabilities (noncurrent)	373		413
Asbestos litigation	295		256
Other	626		697
Total	$	2,324	2,753